Dan Lewis Foundation for Brain Regeneration Research
Dan Lewis Foundation for Brain Regeneration Research
Want to make a donation using Daffy?
Lower your income taxes with a charitable deduction this year when you donate to this non-profit via Daffy.
Do you work for Dan Lewis Foundation for Brain Regeneration Research? Learn more here.
By donating on this page you are making an irrevocable contribution to Daffy Charitable Fund, a 501(c)(3) public charity, and a subsequent donation recommendation to the charity listed above, subject to our Member Agreement. Contributions are generally eligible for a charitable tax-deduction and a yearly consolidated receipt will be provided by Daffy. Processing fees may be applied and will reduce the value available to send to the end charity. The recipient organizations have not provided permission for this listing and have not reviewed the content.
Donations to organizations are distributed as soon as the donation is approved and the funds are available. In the rare event that Daffy is unable to fulfill the donation request to this charity, you will be notified and given the opportunity to choose another charity. This may occur if the charity is unresponsive or if the charity is no longer in good standing with regulatory authorities.
About this organization
Mission
Our mission is to support the creation of new pharmacologic treatments that promote neural cell regeneration, renewed synaptic plasticity, and axonal regrowth to improve the lives of persons with moderate and severe traumatic brain injuries and their families.
About
Activities in support of our mission include - Convene meetings of leading bioscientists to foster collaboration and formulation of coordinated, programmatic research plans. - Establish a blueprint for a specific step-by-step research agenda that exploits new cellular models and assays of brain function as well as new classes of medicines which can specifically target expression of key pathways that regulate CNS plasticity. - Raise funds to support this research agenda and distribute these funds based on rigorous peer review of applications for funding from academic and commercial investigators. - Encourage research partnerships between scientists in academic and business settings to explore the potential of anti-sense oligonucleotides (ASOs) and small molecule medicines to accelerate brain recovery, particularly in the context of rigorous therapy services and repletion of key populations of CNS cells. - Promote research efforts to evaluate the safety and efficacy of various treatment regimens utilizing genomically targeted nucleic acid medicines (ASOs) and/or small molecule medicines to promote neurological recovery in the chronic phase following TBI. - Link with other TBI information and advocacy groups and organizations to disseminate information regarding ongoing research efforts in pioneering medicines to improve outcomes for persons with severe TBI. - Provide support to neuroscientists pursuing research into innovative pharmaceutical approaches to TBI recovery via information, references, professional linkages, and review and consultation regarding grant applications.